Grail, a clinical-stage company developing cancer tests intended to detect early signs of the disease from a small blood sample, has agreed to invest $100 million in a new outpost planned for Research Triangle Park, NC.
The new Grail site will have a laboratory and warehouse space, Gov. Roy Cooper announced Tuesday after an agreement was reached regarding an incentives package from the state. Menlo Park, CA-based Grail says the planned building will house a commercial laboratory focused on processing test samples.
“Expanding to a second site in North Carolina allows us to scale our operations, which will enable us to deliver… Read more »
UNDERWRITERS AND PARTNERS